Abstract:The development of cancer is tightly related to the successful evasion of neoplastic tissue from immune system surveillance, which represents a key obstacle in tumor therapy. Most conventional therapies (surgery, chemotherapy and radiation) target the tumor cells directly or indirectly, while immunotherapy attempts to enhance host anti-tumor response. In a manner similar to surgery, photodynamic therapy (PDT), also a local tumor therapy, aims at tumor ablation in its initial acute phase. Treatment success is mainly determined by tumor eradication and the absence of local recurrences. However, experience gained over several decades of therapeutic application has repeatedly hinted at long term therapeutic effects of PDT, suggesting activation of the immune system by this treatment modality. Such contribution of the immune system to treatment success was widely confirmed in many laboratories in various preclinical and some clinical studies. In this present short review, we wish to present our modest contribution to this potential therapeutic trend describing the immune response upon application of a novel photosensitizing methodology: vascular targeted photodynamic therapy (VTP) developed in our laboratories. This modality differs from classical PDT in most aspects (sensitizer: Pd-bacteriochlorophyll and consequent spectral wavelength in the near infrared, the generated photochemistry, the treatment target, treatment objective, treatment protocol and more). For example in contrast to the tumor cells that constitute the target of classical PDT, the targets of VTP are the tumor-feeding arteries and draining veins whose almost instant occlusion (minutes) leads to tumor blood stasis and eradication. Some of the mechanistic features of the induced immune response, such as innate and acquired cellular and humoral mediators, induction of new antigens, resulting from oxidative modifications and implications for anti-tumor vaccination in this different treatment environment, are discussed. VTP is about to enter phase III clinical trials for the therapy of prostate cancer and the potential involvement of the immune system may contribute an interesting aspect for the understanding and future development of this treatment modality.

Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies

Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors

Recent Advances in Photodynamic Therapy for Vascular Abnormalities

Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP)

Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges

Vascular targeted photodynamic therapy: A review of the efforts towards molecular targeting of tumor vasculature

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

Enhancing Precision in Photodynamic Therapy: Innovations in Light-Driven and Bioorthogonal Activation

Clinical and pre-clinical advances in the PDT/PTT strategy for diagnosis and treatment of cancer

Targeting tumor microenvironment with photodynamic nanomedicine

Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer

The Current Status of Photodynamic Therapy in Cancer Treatment

Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions

Recent Advances in Near Infrared Upconverting Nanomaterials for Targeted Photodynamic Therapy of Cancer

Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy

Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials

Recent advances in photosensitizer materials for light‐mediated tumor therapy

Current Trends and Potential Future Role in the Treatment of Bladder Cancer

Recent Progress in Upconversion Photodynamic Therapy

Clinical development and potential of photothermal and photodynamic therapies for cancer

Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies